These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 17143873

  • 1. Prostate cells express two isoforms of fibroblast growth factor receptor 1 with different affinities for fibroblast growth factor-2.
    Roghani M, Moscatelli D.
    Prostate; 2007 Feb 01; 67(2):115-24. PubMed ID: 17143873
    [Abstract] [Full Text] [Related]

  • 2. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
    Guillonneau X, Tassin J, Berrou E, Bryckaert M, Courtois Y, Mascarelli F.
    J Cell Physiol; 1996 Jan 01; 166(1):170-87. PubMed ID: 8557766
    [Abstract] [Full Text] [Related]

  • 3. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells.
    Antoine M, Wirz W, Tag CG, Mavituna M, Emans N, Korff T, Stoldt V, Gressner AM, Kiefer P.
    Growth Factors; 2005 Jun 01; 23(2):87-95. PubMed ID: 16019430
    [Abstract] [Full Text] [Related]

  • 4. Fibroblast growth factor (FGF)-2 mediates cell attachment through interactions with two FGF receptor-1 isoforms and extracellular matrix or cell-associated heparan sulfate proteoglycans.
    Richard C, Roghani M, Moscatelli D.
    Biochem Biophys Res Commun; 2000 Sep 24; 276(2):399-405. PubMed ID: 11027487
    [Abstract] [Full Text] [Related]

  • 5. Alternatively spliced FGFR-1 isoforms differentially modulate endothelial cell activation of c-YES.
    Zhang P, Greendorfer JS, Jiao J, Kelpke SC, Thompson JA.
    Arch Biochem Biophys; 2006 Jun 01; 450(1):50-62. PubMed ID: 16631103
    [Abstract] [Full Text] [Related]

  • 6. Endogenous fibroblast growth factor-1 or fibroblast growth factor-2 modulate prostate cancer cell proliferation.
    Shain SA, Sarić T, Ke LD, Nannen D, Yoas S.
    Cell Growth Differ; 1996 May 01; 7(5):573-86. PubMed ID: 8732667
    [Abstract] [Full Text] [Related]

  • 7. Expression and splicing of FGF receptor mRNAs during APRE-19 cell differentiation in vitro.
    Alizadeh M, Gelfman CM, Bench SR, Hjelmeland LM.
    Invest Ophthalmol Vis Sci; 2000 Jul 01; 41(8):2357-62. PubMed ID: 10892884
    [Abstract] [Full Text] [Related]

  • 8. Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines.
    Salm SN, Koikawa Y, Ogilvie V, Tsujimura A, Coetzee S, Moscatelli D, Moore E, Lepor H, Shapiro E, Sun TT, Wilson EL.
    J Cell Physiol; 2000 Jul 01; 184(1):70-9. PubMed ID: 10825235
    [Abstract] [Full Text] [Related]

  • 9. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2.
    Shain SA.
    Mol Cancer Res; 2004 Nov 01; 2(11):653-61. PubMed ID: 15561781
    [Abstract] [Full Text] [Related]

  • 10. [The role of human fibroblast growth factor receptor 1-IIIb isoform in proliferation of pancreatic ductal cells and its effects to mitogen-activated protein kinase].
    Liu ZB, Yang YM, Qiao QL, Wan YL, Kornmann M, Huang YT.
    Zhonghua Yi Xue Za Zhi; 2006 Oct 31; 86(40):2812-6. PubMed ID: 17200012
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors.
    Jin C, Wang F, Wu X, Yu C, Luo Y, McKeehan WL.
    Cancer Res; 2004 Jul 01; 64(13):4555-62. PubMed ID: 15231666
    [Abstract] [Full Text] [Related]

  • 13. The cysteine-free fibroblast growth factor 1 mutant induces heparin-independent proliferation of endothelial cells and smooth muscle cells.
    Xue L, Shireman PK, Hampton B, Burgess WH, Greisler HP.
    J Surg Res; 2000 Aug 01; 92(2):255-60. PubMed ID: 10896831
    [Abstract] [Full Text] [Related]

  • 14. Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells.
    Feng S, Wang F, Matsubara A, Kan M, McKeehan WL.
    Cancer Res; 1997 Dec 01; 57(23):5369-78. PubMed ID: 9393762
    [Abstract] [Full Text] [Related]

  • 15. Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate.
    Ittman M, Mansukhani A.
    J Urol; 1997 Jan 01; 157(1):351-6. PubMed ID: 8976296
    [Abstract] [Full Text] [Related]

  • 16. The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer.
    Kwabi-Addo B, Wang J, Erdem H, Vaid A, Castro P, Ayala G, Ittmann M.
    Cancer Res; 2004 Jul 15; 64(14):4728-35. PubMed ID: 15256439
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fibroblast growth factor-1 induction of delayed-early mRNA expression in NIH 3T3 cells is prolonged by heparin addition.
    Donohue PJ, Hsu DK, Guo Y, Burgess WH, Winkles JA.
    Exp Cell Res; 1997 Jul 10; 234(1):139-46. PubMed ID: 9223379
    [Abstract] [Full Text] [Related]

  • 20. Interactions of pancreatic cancer and stellate cells are mediated by FGFR1-III isoform expression.
    Tian X, Chen G, Zhou S, Henne-Bruns D, Bachem M, Kornmann M.
    Hepatogastroenterology; 2012 Jul 10; 59(117):1604-8. PubMed ID: 22683979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.